Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine

Annals of Neurology

Volumn 47, Issue 4 SUPPL. 1, 2000, Pages

  Lozano, Andres M ^a,d   Lang, Anthony E ^b   Levy, Ron ^c   Hutchison, William ^a,c   Dostrovsky, Jonathan ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Division of Neurology   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE;

CELL ACTIVITY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSKINESIA; GLOBUS PALLIDUS; HUMAN; NERVE CELL; NEUROSURGERY; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

ACTION POTENTIALS; AFFECT; APOMORPHINE; DOPAMINE AGONISTS; DYSKINESIA, DRUG-INDUCED; ELECTROPHYSIOLOGY; GLOBUS PALLIDUS; HUMANS; NEURONS; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS;

EID: 0034027547     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-520
2. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151
3. Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A, eds. The basal ganglia II. New York: Plenum Press, 1987:15-427
4. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285
5. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998;339:1130-1143
6. Waszczak BL, Lee EK, Ferraro T, et al. Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia. Brain Res 1984;306:307-318
7. Waszczak BL, Lee EK, Tamminga CA, Walters JR. Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats. J Neurosci 1984; 4:2369-2375
8. Kreiss DS, Mastropietro CW, Rawji SS, Walters JR. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 1997;17: 6807-6819
9. Filion M. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey. Brain Res 1979;178: 425-441
10. Filion M, Tremblay L, Bédard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:152-161
11. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628
12. Lozano A, Hutchison W, Kiss Z, et al. Methods for microelectrode-guided posteroventral pallidotomy [see comments]. J Neurosurg 1996;84:194-202
13. Hutchison WD, Levy R, Dostrovsky JO, et al. Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann Neurol 1997;42:767-775
14. Hutchison WD, Lozano AM, Davis KD, et al. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. Neuroreport 1994;5:1533-1537
15. Lozano AM, Hutchison WD, Kiss Z, et al. Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg 1996; 84:194-202
16. Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997; 337:1036-1042
17. Lozano AM, Lang AE, Gàlvez-Jiménez N, et al. GPi pallidotomy improves motor function in patients with Parkinson's disease. Lancet 1995;346:1383-1387
18. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855
19. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons [see comments]. Science 1990;250:1429-1432
20. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 1992;68:1859-1866
21. 11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl) 1997;133:396-404
22. 125I]epidepride. Brain Res 1993;609:237-243
23. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6: 751-758
24. Hassani OK, Francois C, Yelnik J, Féger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res 1997;749:88-94
25. Brown LL, Markman MH, Wolfson LI, et al. A direct role of dopamine in the rat subthalamic nucleus and an adjacent intrapeduncular area. Science 1979;206:1416-1418
26. Aebischer P, Schultz W. The activity of pars compacta neurons of the monkey substantia nigra is depressed by apomorphine. Neurosci Lett 1984;50:25-29
27. Baring MD, Walters JR, Eng N. Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion. Brain Res 1980;181:214-218
28. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J Neurophysiol 1992;68:1850-1858
29. Matsumura M, Tremblay L, Richard H, Filion M. Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 1995;65: 59-70
30. Burbaud P, Bonnet B, Guehl D, et al. Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey. Brain Res 1998;780:102-107
31. Kato M, Kimura M. Effects of reversible blockade of basal ganglia on a voluntary arm movement. J Neurophysiol 1992;68:1516-1534
32. Bejjani B, Damier P, Arnulf I, et al. Pallidal stimulation for Parkinson's disease. Two targets? Neurology 1997;49(6):1564-1569
33. Krack P, Pollak P, Limousin P, et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 1998;43(2): 180-192
34. Merello M, Cammarota A, Betti O, et al. Involuntary movements during thermolesion predict a better outcome after microelectrode guided posteroventral pallidotomy. J Neurol Neurosurg Psychiatry 1997;63:210-213
35. Hoover JE, Strick PL. Multiple output channels in the basal ganglia. Science 1993;259:819-821
36. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. N Engl J Med 1988;318:876-880
37. Papa SM, Desimoine R, Fioran M, Oldfield EH. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann Neurol 1999;46(suppl 5):732-738